AstraZeneca Pharma gains 3% on plan to launch cancer drug in India News News / News 6 years ago 464 Views comments Osimertinib is an oral anti-cancer drug for management of lung cancer. Read more
News Gujarat Rajya Sabha polls: Congress wants EC probe over alleged misuse of power News / News - 6 years ago
News Supreme Court issues notice to Centre, MP govt on encounter killing of prisoners News / News - 6 years ago
News Beware of free WiFi at coffee shops, railway stations! 96% people risk giving up personal info while using public WiFi: Symantec News / News - 6 years ago
Comments